Avid Bioservices Inc (CDMO)

[biopharm]

This video below is an EYE opener for some that have any doubts : listen closely around the 3:14 min mark - 10 min and combine all this with the sabotage against Peregrine Pharmaceuticals.

----------------------------------------

The Roles of Bioethics in Industry: Perspectives from an Insider -- Dr. Llew Keltner

Ok, so we have Llew Keltner and joining the BOD, finally updated online... is Rahul. This is the same Rahul that mentions Big Pharma Mafia a couple conf calls ago of Peregrine Pharmaceuticals. Why all of a sudden was he lured to Pelican

Rahul R Jasuja, PhD.

Dr. Jasuja is currently Managing Director, Biotechnology Research at Noble Life Science Partners (NLSP). Prior to NLSP, he was Vice President, Corporate Development, at Idera Pharmaceuticals, focused on developing toll-like receptor based immune-modulators. At Idera, his role included business development, alliance management, pipeline strategy, technology communication for out-licensing efforts. He contributed to the development strategy of Idera’s novel immune modulator (a toll-like receptor 7/9 antagonist) for autoimmune & inflammatory disease. Previously Dr. Jasuja held progressively senior positions in the biotechnology capital markets at Techvest, Rodman & Renshaw, and MDB Capital Group. He brings more than 20 years’ experience in the biotechnology field encompassing corporate/business development, technology due-diligence, equity research and academic research. He obtained his B.Sc. in Microbiology & Biochemistry from the University of Bombay (India), and his M.S. in Microbiology from the University of Montana, Missoula, where he studied the role of bacterial cell wall immune-modulators on arachidonic acid metabolism and inflammatory pathways in macrophages. Dr. Jasuja received his Ph.D. in Immunology from Tufts University School of Medicine, Boston, where he explored aspects of T cell activation and the subsequent regulation of adhesion receptors in the immune response. He conducted doctoral and post-doctoral research at Harvard Medical School, Boston, in the Dept. of Hematology & Oncology at Beth Israel Deaconess Medical Center.

http://www.pelicantherapeutics.com/aboutus.php